Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...
17d
MedPage Today on MSNGLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression RiskIn older adults with diabetes, GLP-1 receptor agonists were tied to a slightly lower risk for depression compared with one diabetes drug class but not another, a target emulation trial using Medicare ...
The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...
The uptake of GLP-1 has surged since 2022, mainly in US. Read our takeaways from the UBS Evidence Lab survey on key trends in GLP-1 consumer behaviour GLP-1s, also known as glucagon-like peptide 1, ...
“In the brain, GLP-1 receptors act like a stop light and tell certain areas of the brain to stop releasing dopamine, the feel-good chemical that reinforces compulsive or addictive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results